Current Prices from Milestone Pharmaceuticals Inc. - Common Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	MIST	USD	13.06.2025 21:20	1,62 USD	1,67 USD -2,99 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-6,90 %	35,56 %	-20,20 %	-9,50 %	13,29 %	-60,29 %

Company Profile for Milestone Pharmaceuticals Inc. - Common Shares Share

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Company Data

Name Milestone Pharmaceuticals Inc. - Common Shares

Company Milestone Pharmaceuticals Inc.

Symbol MIST

Website https://www.milestonepharma.com

Primary Exchange

NASDAQ

ISIN CA59935V1076

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Joseph G. Oliveto M.B.A.

Market Capitalization 47 Mio

Country Canada

Currency USD

Employees 0,0 T

Address 1111 Dr. Frederik-Philips Boulevard, H4M 2X6 Montreal

IPO Date 2019-05-09

Ticker Symbols

Name	Symbol
NASDAQ	MIST

More Shares

Investors who Milestone Pharmaceuticals Inc. - Common Shares hold also have the following shares in their portfolio:

DT.HYP.BK.MTN.HPF S.496 Bond

DUA CAPITAL 21/26 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog